Advisory Services Network’s VanEck Biotech ETF BBH Stock Holding History

Advisory Services Network’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-608	Closed	-$101K	–	1653
2023 Q4	$101K	Buy	+608	New	+$93.6K	﹤0.01%	1647
2023 Q2	–	Sell	-600	Closed	-$97.3K	–	1641
2023 Q1	$97.3K	Sell	600 -75	-11%	-$12.1K	﹤0.01%	1662
2022 Q4	$108K	Buy	+675	New	+$107K	﹤0.01%	1569
2019 Q4	–	Sell	-2	Closed	–	–	3080
2019 Q3	$0	Hold	2	–	–	﹤0.01%	2798
2019 Q2	$0	Buy	+2	New	+$247	﹤0.01%	2803
2016 Q3	$8K	Buy	+71	New	+$8.09K	﹤0.01%	1362

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

CIG

Consolidated Investment Group Englewood, Colorado $922M AUM 28.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Advisory Services Network's BBH Position: Q1 2024 in Review

Advisory Services Network sold out of VanEck Biotech ETF (BBH) in Q1 2024, closing a stake of 608 shares — an estimated $101K sold.

Advisory Services Network first reported a position in BBH in Q3 2016 and held it in 6 quarters. The position peaked at $108K in Q4 2022. 113 funds tracked by Wall St. Rank hold BBH as of Q1 2024.

Advisory Services Network reported no remaining VanEck Biotech ETF position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 608 VanEck Biotech ETF shares in Q1 2024, an estimated $101K.
Advisory Services Network first reported a position in VanEck Biotech ETF in Q3 2016 and held it in 6 quarters.
Advisory Services Network's VanEck Biotech ETF position peaked at $108K in Q4 2022.
113 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.